Related Experiment Videos
Interferon effect on glycosaminoglycans in mouse glioma in vitro
1University of South Florida, College of Medicine, Department of Neurology, Tampa.
Abstract:
The effect of mouse interferon alpha/beta (MuIFN alpha/beta) on the production of glycosaminoglycans (GAGs) by mouse glioma G-26 in vitro was evaluated. Two GAG species secreted extracellularly by the mouse glioma G-26 were isolated using cellulose acetate electrophoresis. They were identified as hyaluronic acid (HA) and chondroitin sulfate (CS) following enzymatic digestion with enzymes: hyaluronidase and chondroitinase ABC. Further characterization of CS by enzymatic digestion with specific chondroitinases for chondroitin 4-sulfate (CSA) and chondroitin 6-sulfate (CSC), revealed that the isolated CS was neither CSA nor CSC. Therefore, it may be either chondroitin sulfate B (CSB) (dermatan sulfate) or one of the 'chondroitin sulfate isomers' (D-H). The three day incubation of glioma G-26 cells with 8 x 10-8 x 10(4) U/ml of MuIFN alpha/beta resulted in a dose dependent inhibition of cell proliferation measured by 3H-thymidine incorporation and the MTT assay. The significant decrease of the CS (p < 0.008) but not the HA level, (measured densitometrically), was observed following 72 hours (hrs) incubation of G-26 cells with 8 x 10(3) U/ml of MuIFN alpha/beta (IFN treated cells: 0.03 +/- 0.007 integrated optical density (IOD); control cells: 0.07 +/- 0.01 IOD). The decreased CS production may be the underlying cause of IFN mediated inhibition of glioma cell proliferation.
Insights
Mouse interferon alpha/beta (MuIFN alpha/beta) significantly reduced chondroitin sulfate (CS) production in glioma cells, suggesting this decrease may inhibit cell proliferation. This finding offers insights into interferon
Area of Science:
- Biochemistry
- Cell Biology
- Immunology
Background:
- Glycosaminoglycans (GAGs) play crucial roles in cellular processes, including cell proliferation and extracellular matrix composition.
- Interferons (IFNs) are known immunomodulatory cytokines with potential anti-cancer effects.
- Glioma cells produce specific GAGs that may influence their growth and behavior.
Purpose of the Study:
- To investigate the impact of mouse interferon alpha/beta (MuIFN alpha/beta) on glycosaminoglycan (GAG) production by mouse glioma G-26 cells in vitro.
- To determine if changes in GAG production correlate with the anti-proliferative effects of MuIFN alpha/beta on glioma cells.
Main Methods:
- Isolation and identification of extracellular GAGs (hyaluronic acid and chondroitin sulfate) from mouse glioma G-26 cells using cellulose acetate electrophoresis and enzymatic digestion.
- Characterization of chondroitin sulfate (CS) species using specific chondroitinases.
- Assessment of MuIFN alpha/beta's effect on glioma cell proliferation via 3H-thymidine incorporation and MTT assay.
- Quantification of GAG levels (HA and CS) using densitometry after IFN treatment.
Main Results:
- MuIFN alpha/beta demonstrated a dose-dependent inhibition of glioma G-26 cell proliferation.
- A significant decrease in chondroitin sulfate (CS) levels was observed in MuIFN alpha/beta-treated cells compared to controls.
- Hyaluronic acid (HA) levels were not significantly affected by MuIFN alpha/beta treatment.
- The characterized CS was neither chondroitin 4-sulfate nor chondroitin 6-sulfate, suggesting it may be chondroitin sulfate B or an isomer.
Conclusions:
- MuIFN alpha/beta inhibits mouse glioma cell proliferation in vitro.
- The reduction in chondroitin sulfate (CS) production is a key effect of MuIFN alpha/beta treatment on glioma cells.
- Decreased CS production may be a mechanism underlying the anti-proliferative action of interferons on gliomas.